調査・レポート
2026年9月14日•1分で読めます
Global Type 1 Diabetes Cases Projected to Rise 30% by 2049, Study Finds
A Danish research team projects worldwide type 1 diabetes patients will increase from 9.4 million to about 12.1 million by 2049, a 30% rise, with new cases up 14%.
調査・レポート
2026年9月6日•1分で読めます
BioSolution and Merck Life Science Unveil Animal‑Free Testing Solution at CPHI Korea 2026
BioSolution partnered with Merck Life Science to showcase a combined 3D human tissue model and precision analysis workflow for animal‑alternative testing at CPHI Korea 2026.
調査・レポート
2026年8月30日•1分で読めます
Acelra Presents Phase 1 Results of ACL-508 at NLA Conference
Acelra, the new‑drug subsidiary of Jonggeundang, reported Phase 1 data for its CETP inhibitor ACL‑508, aimed at lowering LDL‑C and raising HDL‑C, at the NLA annual meeting in Chicago.
調査・レポート
2026年8月24日•1分で読めます
PMDA Workshop on New Approach Methodologies (NAMs) Held after ICCR‑20
The Pharmaceuticals and Medical Devices Agency (PMDA) held a workshop on New Approach Methodologies (NAMs) following the ICCR‑20 symposium.
1